10-Q · May 14, 2026
ROC experienced a significant decline in revenue of 20% year-over-year to $2.55 million in Q1 2026, alongside a negative EPS of -$0.18. Despite lower revenues in key segments like ROC SDK and ROC Enroll, products like…
Earnings analysis · 10-Q
ROC earnings analysis
Filed August 13, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q excerpt does not include the current-period income statement, balance sheet, cash-flow statement, segment results or MD&A, so operating trends and valuation metrics cannot be assessed from the…
Read full summary
The supplied 10-Q excerpt does not include the current-period income statement, balance sheet, cash-flow statement, segment results or MD&A, so operating trends and valuation metrics cannot be assessed from the available text. The principal updates are the pending ZTC acquisition, which carries closing, dilution and future expense risks, and litigation with approximately $179.1 million of claimed damages. Management reported effective disclosure controls as of June 30, 2026, but provided no quantitative guidance.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Controls assessed as effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026. The company also reported no changes during the three months ended June 30, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
-
ZTC acquisition initiated
ROC entered into a Purchase Agreement to acquire ZTC on June 23, 2026. The proposed consideration includes $500,000 in cash, $2,500,000 in restricted common-stock shares and up to $7,000,000 in revenue-share payments over seven years.
-
No unregistered sales or repurchases
The filing states that no unregistered securities were sold during the quarter and that the company performed no stock repurchases in any month of the quarter.
What to watch
-
ZTC closing and cost risk
The ZTC transaction remains subject to regulatory approvals, third-party consents, key-personnel employment agreements and completion of audits of ZTC's 2024 and 2025 financial statements. ROC expects significant legal, accounting and advisory costs whether or not the transaction closes.
-
Dilution and acquisition expense
The ZTC acquisition could dilute existing shareholders through $2,500,000 of restricted shares and $500,000 of restricted stock units. ROC expects forfeitable equity and revenue-share amounts to be recognized as compensation expense after closing, potentially reducing reported operating results materially.
-
$179.1 million litigation claim
ROC is defending litigation filed in March 2026 in the High Court of England and Wales in which the plaintiff seeks approximately $179.1 million. The company has recorded no loss accrual because the matter is at an early stage and cannot currently be estimated; insurance may not cover the full cost.
Management's outlook
No quantitative revenue or EPS guidance was provided in the supplied 10-Q excerpt.
Earlier filings 2
10-K · March 31, 2026
ROC positions itself as a U.S.-native leader in Vision AI and multimodal biometrics, emphasizing NIST-ranked accuracy and extreme algorithmic efficiency (e.g., a latent fingerprint algorithm that is described as capable…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.